Cash Flow Trend (5 Years)
Investing CF
Operating CF
Financing CF
78.7M0
-73.2M
00002020
2021
2022
2023
78.7M
-59M
-73.2M
ADAPYAdaptimmune Therapeutics plc$ --
Adaptimmune Therapeutics plc
ADAPY
$ -
-
Review operating, investing, and financing cash flow trends alongside detailed breakdowns.
account_balanceCash Flow (CF) Summary
No cash flow data available
2024
analyticsInvestment Efficiency Analysis
Operating CF vs Investing CF
Operating CF
Investing CF
100M50M0-50M-100M
20202021202220232024
waterfall_chartCash Flow Bridge (FY2024 Full Year)
Beginning / Ending
Increase
Decrease
200M150M100M50M0-50M
147M
Beginning Cash
-73.2M
Operating CF
-59M
Investing CF
78.7M
Financing CF
-402,000
Other
93.2M
Ending Cash
Cash Flow Details
Item
Net Income from Continuing Operations
Depreciation and Amortization
Depreciation and Amortization
Stock-based Compensation
Other Non-cash Items
Adjustments to Net Income
Other Operating Activity
Change in Working Capital
Change in Account Receivables
Change in Trade Receivables
Change in Inventory
Change in Payables and Accrued Expenses
Other Working Capital Changes
Cash Flow from Operating Activities
Net Fixed Asset Activity
Net Investment Securities Activity
Other Investing Activity
Cash Flow from Investing Activities
Net Borrowings
Net Issuance / Repurchase of Stock
Issuance of Capital Stock
Total Dividends Paid
Net Dividends Paid
Treasury / Other Financing Activity
Cash Flow from Financing Activities
Beginning Cash and Cash Equivalents
Net Change in Cash and Cash Equivalents
Net Change in Cash and Cash Equivalents
Exchange Rate Changes
Ending Cash and Cash Equivalents
Free Cash Flow
Unlock Long-Term Cash Flow Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.